Multiple Cancers and Diffuse Bony Metastases

  • Daphne Y. Tong
Part of the Medical Radiology book series (MEDRAD)

Abstract

Twelve years ago, a man who is now 81 years old had stage II adenocarcinoma of the left breast managed by radical mastectomy. Ten years ago, he had a well-differentiated adenocarcinoma of the prostate, stage A1, treated by irradiation. He now has fatigue with pain in his left shoulder and back. Imaging studies show a large excavating mass in the right lower lobe of the lung extending to the pleura with a large effusion. Lytic and blastic lesions are seen in the thoracic and lumbar spine and the right acetabula. Bone scan reveals increased uptake in the ribs bilaterally and in the left hemipelvis. A homogeneously enlarged prostate has been found with a prostate-specific antigen (PSA) level of 5.25, elevated serum alkaline phosphatase, and a hemoglobin of 10 g/dl.

Keywords

Fatigue Adenocarcinoma Testosterone Fractionation Oncol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aichner F, Poewe W, Rogalsky W et al. (1987) Magnetic resonance imaging in the diagnosis of spinal cord diseases. J Neurol Neurosurg Psychiatr 48:1220CrossRefGoogle Scholar
  2. Allhoff EP, Proppe KH, Chapman CM et al. (1983) Evaluation of prostate-specific acid phosphatase and prostate-specific antigen in identification of prostate cancer. J Urol 129: 315–318PubMedGoogle Scholar
  3. Ariel IM, Hassouna H (1985) Carcinoma of the prostate. The treatment of bone metastases by radioactive phosphorous (32P). Int Surg 70: 63–66PubMedGoogle Scholar
  4. Aziz H, Choi K, Sohn C et al. (1986) Comparison of 32P therapy and sequential hemibody irradiation (HBI) for bony metastases as methods of whole body irradiation. Am J Clin Oncol 9:264–268PubMedCrossRefGoogle Scholar
  5. Bayly TC, Kisner DL, Sybert A et al. (1978) Tetracycline and quinacrine in the control of malignant pleural effusions: a randomized trial. Cancer 41:1188PubMedCrossRefGoogle Scholar
  6. Bleehen NM, Girling DJ, Fayers PM et al. (1990) Two consecutive controlled clinical trials of palliative radiotherapy for inoperable non small cell lung cancer (NSCLC). Proceedings of the first international consensus workshop on radiation therapy in the treatment of metastatic and locally advanced cancer. (Abstr. 3B-1)Google Scholar
  7. Blitzer PH (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastases. Cancer 55: 1468–1472PubMedCrossRefGoogle Scholar
  8. Cole DJ (1989) A randomized trial of a single treatment versus conventional fraction in the palliative radiotherapy of painful bone metastasis. Clin Oncol 1: 59–62CrossRefGoogle Scholar
  9. Cornell CN, Lane JM (1987) Specific sites of metastatic disease and emergencies: management of pathologic fractures. In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds) Breast diseases. Lippincott, Philadelphia, pp 525–532Google Scholar
  10. Doberauer C, Niederle N, Schmidt CG (1988) Advanced male breast cancer treatment with the LH-RH analogue Buserelin alone or in combination with the antiandrogen flutamide. Cancer 62:474–478PubMedCrossRefGoogle Scholar
  11. Eisenhut M, Berberich R, Kimmig B et al. (1986) Iodine-131-labelled diphosphonates for palliative treatment of bone metastases: II preliminary clinical results with Iodine-131 BPD3. J Nucl Med 27:1255–1261PubMedGoogle Scholar
  12. Feiner HD, Gonzalea R (1982) Carcinoma of the prostate with a typical immunohistologic features: clinical and histologic correlates. Am J Surg Pathol 10: 765–770Google Scholar
  13. Fowler JE Jr, Whitmore WF Jr (1982) Consideration for the use of testosterone with systemic chemotherapy in prostate cancer. Cancer 49:1373–1377PubMedCrossRefGoogle Scholar
  14. Garmatis CJ, Chu FCH (1978) The effectiveness of radiation therapy in the treatment of bone metastases from breast cancer. Radiology 126:235–237PubMedGoogle Scholar
  15. Gilbert RW, Kim JH, Posner JB (1978) Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 3:40–51PubMedCrossRefGoogle Scholar
  16. Greenberg HS, Kim JH, Posner JB (1980) Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 8: 361–366PubMedCrossRefGoogle Scholar
  17. Griffith H, Muggia FM (1989) Male breast cancer: update on systemic therapy. Reviews on Endocrine-Related Cancer 31:5–11Google Scholar
  18. Gupta N, Opfell RW, Padova C et al. (1980) Intrapleural bleomycin vs tetracycline for control of malignant pleural effusions. A randomized study. Am Soc Clin Oncol C-189: 366 (abstract)Google Scholar
  19. Kornblith PL, Cassady JR (1985) Central nervous system emergencies. In: DeVita VT, Hellman S, Rosenberg SA (eds) Principles and practice of oncology. 2nd edn. Lippincott, Philadelphia, p 1960Google Scholar
  20. Leff A, Honeywell PC, Costello J (1978) Pleural effusion from malignance. Ann Intern Med 88: 532PubMedGoogle Scholar
  21. Madesn EL (1983) Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy × 6 versus 10 Gy × 2. Int J Radiat Oncol Biol Phys 9:1775–1779Google Scholar
  22. Maxfield JR, Maxfield JJR, Maxfield WS (1958): The use of radioactive phosphorous and testosterone in metastatic bone lesions from breast and prostate. South Med J 51: 320–327PubMedCrossRefGoogle Scholar
  23. Meyskens FL, Tormey DC, Neifeld JP (1976) Male breast cancer: a review. Cancer Treat Rev 3: 83–93PubMedCrossRefGoogle Scholar
  24. O’Neill W, Spurr C, Muss H et al. (1980) A prospective study of chest tube drainage and tetracycline sclerosis versus chest tube drainage in the treatment of malignant pleural effusion. Proc Am Soc Clin Oncol 21: 349Google Scholar
  25. Penn CRH (1976) Single dose and fractionated palliative irradiation for osseous metastases. Clin Radiol 29:405–408CrossRefGoogle Scholar
  26. Poulter CA, Cosmatos D, Rubin P et al. (1992) A report of RTOG 8206: a phase III study of whether the addition of single-dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys 23:207–214PubMedCrossRefGoogle Scholar
  27. Reddy EK, Robinson RG, Mansfield CM (1986) Strontium-89 therapy for palliation of bone metastases. J Natl Med Assoc 78:27–32PubMedGoogle Scholar
  28. Salazar OM, Rubin P, Hendricksoon FR et al. (1986) Singledose half-body irradiation for palliation of multiple bone metastases from solid tumors: final radiation therapy oncology group report. Cancer 58:29–36PubMedCrossRefGoogle Scholar
  29. Slawson RG, Scott RM (1979) Radiation therapy in bronchogenic carcinoma. Radiology 132:175–176PubMedGoogle Scholar
  30. Swain SM (1991) Review of the article “Management of male breast cancer.” Oncology 5(3): 47–48Google Scholar
  31. Tochner Z, Weshler Z, Rizel S, Fuks Z (1982) Fractionated hemiskeletal irradiation for widespread carcinomatous metastases to bone Int J Radiat Oncol Biol Phys 8: 128 (abstract)Google Scholar
  32. Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases: final results of the study by radiation oncology group. Cancer 50: 893–899PubMedCrossRefGoogle Scholar
  33. Vargha ZO, Glicksman AS, Boland J (1969) Single-dose radiation therapy in the palliation of metastatic disease. Radiology 93:1180–1184Google Scholar
  34. Vorobiof DA, Falkson G (1987) Nasally administered buserelin-inducing complete remission of lung metastases in male breast cancer. Cancer 59:688–689PubMedCrossRefGoogle Scholar
  35. Zaloznek AJ, Oswald SG, Langin M (1983) Intrapleural tetracycline in malignant pleural effusion. A randomized study. Cancer 51:752CrossRefGoogle Scholar
  36. Zelefsky MJ, Scher HI, Forman JD et al. (1989) Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single-dose and fractionated regiments. Int J Radiat Oncol Biol Phys 17: 1281–1285PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • Daphne Y. Tong
    • 1
  1. 1.Radiation OncologyGroup Health HospitalEast SeattleUSA

Personalised recommendations